CCO Slideset

Fine-Tuning Antiretroviral Therapy in HIV-Infected Patients With Virologic Suppression: Strategies to Address Toxicity, Convenience, and Quality of Life

Source: Fine-Tuning Antiretroviral Therapy in HIV-Infected Patients With Virologic Suppression: Strategies to Address Toxicity, Convenience, and Quality of Life

Fine-Tuning Antiretroviral Therapy in HIV-Infected Patients With Virologic Suppression: Strategies to Address Toxicity, Convenience, and Quality of Life


Faculty:

Paul E. Sax, MD
  • Paul E. Sax, MD

CME CREDIT INFORMATION

Release Date: 01/30/07

Expiration Date: 01/29/08


Physicians: maximum of 1.5 AMA PRA Category 1 Credits™

Status: Please log in to view status

Begin the CCO Slideset

Learning Objectives

Upon completion of this activity, participants should be able to:

  • List the various possible rationales for modifying antiretroviral therapy in patients with virologic suppression
  • Discuss antiretroviral switch strategies designed to improve the convenience of a suppressive regimen
  • Describe changes to antiretroviral therapy designed to prevent the development of adverse effects or to ameliorate toxicities that are already present

Review and download slides summarizing the most clinically relevant data on antiretroviral therapy modification in patients with virologic suppression.

This slide presentation is in Microsoft PowerPoint format and is available for download within the CME-certified module.

Topics covered include:

  • Fine-Tuning Antiretroviral Therapy to Improve Regimen Convenience
  • Fine-Tuning Antiretroviral Therapy to Manage or Prevent Toxicity
  • Clinical Trials of Antiretroviral Therapy Modification
Disclaimer: The materials published on the Clinical Care Options Web site reflect the views of the reviewers or authors of the CCO material, not those of Clinical Care Options, LLC, the CME provider, or the companies providing educational grants. The materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or using any therapies described in these materials.

Jointly sponsored by Postgraduate Institute for Medicine and Clinical Care Options, LLC.

Contact Info

Educational grant provided by:

Educational grants support only the CME-certified components of this program.